The Fourth Khat Research Program (KRP) Symposium
(Rabat, Morocco, June 13, 2013)
KRP is supported by grants from the National Institutes of Health (NIH)*,
the University of Minnesota, the International Brain Research Organization (IBRO),
and several collaborating international universities
You are invited to the fourth KRP international symposium. This symposium will be conducted within the 11th SONA Conference, Rabat, Morocco, June 13-17, 2013
ABOUT THE KRP
Khat (Catha edulis) is a stimulant plant native to tropical East Africa and the Arabian Peninsula. It is widely used in East Africa and the Middle East and among immigrant communities in Europe, North America, and Australia. Khat is a controlled substance in many countries, but is legally available in many others. The principal psychoactive constituent of khat is the alkaloid cathinone. Experimental studies in animals show that cathinone induces many of the pharmacological and behavioral effects similar to those of amphetamine.
The Khat Research Program (KRP) is a multidisciplinary research and training program that was developed to address critical questions related to the understanding of acute and chronic effects of khat use on health and brain functions. The program is partially funded by the National Institutes of Health and the University of Minnesota. The initial phase of the program focuses on neurobehavioral and health effects of chronic khat use. The KRP forms the core model for future research initiatives on khat and concurrent use of other substances, including tobacco and alcohol. The program is conducted in collaboration with multiple universities in the U.S., Europe, Africa, and the Middle East.
In this symposium we will present recent basic and clinical studies on the influence of chronic khat use and will cover new approaches to investigating effects of khat.
KRP partners and invited international speakers will participate in this symposium.
For more information about the KRP please contact the KRP coordinator at email@example.com